Pharmaceutical Interventions for Emotionalism After Stroke
Stroke 41:e460-e461, Hackett,M.L., et al, 2010
Neonatal Cerebral Sinovenous Thrombosis From Symptom to Outcome
Stroke 41:1382-1388, Berfelo,F.J., et al, 2010
Critical Vasospasm During Fingolimod (FTY720) Treatment in a Patient With Multiple Sclerosis
Neurol 74:2022-2024, Schwarz,A., et al, 2010
Diagnostic Yield of Double-Dose Gadobutrol in the Detection of Brain Metastasis: Intraindividual Comparison With Double-Dose Gadopentetate Dimeglumine
AJNR 31:1055-1058, Kim,E.S., et al, 2010
Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
NEJM 362:2185-2193, Jentink,J., et al, 2010
Perioperative Visual Loss in Ocular and Nonocular Surgery
Clin Ophthalmol 4:531-546, Berg, K.T.,et al, 2010
Incidence, Radiographical Features, and Proposed Mechanism for Pneumocephalus from Intravenous Injection of Air
West J Emerg Med 11:180-185, Tran, P.,et al, 2010
Primary Central Nervous System Post-Transplantation Lymphoproliferative Disorder
CANCER 16:863-870, Cavaliere, R.,et al, 2010
What if the sexual headache is not a joke?
BJMP 3:304-308, Redelman, M., 2010
Hypokalemia
eMedicine Sept, Verive,M.J., 2009
Acute Limbic Encephalitis and Glutamic Acid Decarboxylase Antibodies:A Reality?
J Neurosci 287:69-71, Blanc,F.,et al, 2009
Limbic Encephalitis Associated with Anti-GAD Antibody and Common Variable Immune Deficiency
Dev Med Child Neurol 51:563-567, Akman,C.I.,et al, 2009
Spinal Metastasis and Metastatic Disease to the Spine and Related Structures
eMedicine March, Tse,V., 2009
Voltage-gated Potassium Channel-associated Limbic Encepahlitis in the West of Scotland:Case Reports and Literature Review
Scott Med J 54:27-31, Reid,J.M.,et al, 2009
Severe Cardiac Failure in a Patient with Multiple Sclerosis Following Low-Dose Mitoxantrone Treatment
Neurol 73:991-993, D�rr,J.,et al, 2009
DNA �-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model
JAMA 302:1796-1802, Lambracht-Washington,D.,et al, 2009
Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009
CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009
Effect of Glatiramer Acetate on Conversion to Clinically Definite Multiple Sclerosis in Patients with Clinically Isolated Syndrome (PreCISe study): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 374:1503-1511, 1475, Martinelli,G.,et al, 2009
Perioperative Risk Factors for Short Term Shunt Revisions in Adult Hydrocephalus Patients
JNNP 80:1248-1253, 1185, Farahmand,D.,et al, 2009
Reduced Level of Consciousness from Baclofen in People with Low Kidney Function
BMJ 340:b4559, Su,W.,et al, 2009
Road Safety in Drivers With Parkinson Disease
Neurol 73:2112-2119, Uc,E.,et al, 2009
Functional and Cognitive Outcome in Prolonged Refractory Status Epilepticus
Arch Neurol 66:1505-1509, Cooper,A.,et al, 2009
Limbic Encephalitis Associated With Antibodies to the NMDA Receptor in Hodgkin Lymphoma
Neurol 73:2039-2040, Zanid,M.S.,et al, 2009
Delayed Cerebral Thrombosis After Initial Good Recovery From Pneumococcal Meningitis
Neurol 73:1988-1995, Schut,E.S.,et al, 2009
Ganglionic Acetylcholine Receptor Autoantibody: Oncological, Neurological, and Serological Accompaniments
Arch Neurol 66:735-741, McKeon,A.,et al, 2009
Systemic Review of the Perioperative Risks of Stroke or Death After Carotid Angioplasty and Stenting
Stroke 40:e683-e693, Touz�,E.,et al, 2009
Intravenous Thrombolysis in Stroke Attributable to Cervical Artery Dissection
Stroke 40:37772-3776, Engelter,S.,et al, 2009
The Microbleed Anatomical Rating Scale (MARS): Reliability of a Tool to Map Brain Microbleeds
Neurol 73:1759-1766, Gregoire,S.,et al, 2009
Rapid Appearance of New Cerebral Microbleeds After Acute Ischemic Stroke
Neurol 73:1638-1644, 1614, Jeon,S.,et al, 2009
Paraneoplastic Syndromes Affecting Brain and Cranial Nerves
UpToDate May 2009, Dalmau,J. &Rosenfeld,M., 2009
Multifocal Paraneoplastic Cortical Encephalitis Associated With Myasthenia Gravis and Thymoma
Arch Neurol 66:1407-1409, Hammoud,K.,et al, 2009
Idiopathic Intracranial Hypertension in Men
Neurol 72:304-309, Bruce,B.B.,et al, 2009
Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009
Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009
Assessment of Potential Drug Interactions in Patients with Epilepsy: Impact of Age and Sex
Neurol 72:419-425, Gidal,B.E.,et al, 2009
Predictors of Driving Safety in Early Alzheimer Disease
Neurol 72:521-527, Dawson,J.D.,et al, 2009
MR Imaging Features of Isolated Cortical Vein Thrombosis: Diagnosis and Follow-Up
AJNR 30:344-348, Boukobza,M.,et al, 2009
Toxic and Drug-Induced Myopathies
JNNP 80:832-838, Dalakas,M.C., 2009
Superficial Siderosis in the General Population
Neurol 73:202-205, Vernooij,M.W.,et al, 2009
Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity
Arch Neurol 66:865-869, Orr,C.F. &Ahlskog,E., 2009
Neurological Consequences of Atrioesophageal Fistula After Radiofrequency Ablation in Atrial Fibrillation
Arch Neurol 66:884-887, St�llberger,C.,et al, 2009
Long-Term Effects of Pallidal Deep Brain Stimulation in Tradive Dystonia
Neurol 73:53-58, Gruber,D.,et al, 2009
Dabigatran Versus Warfarin in Patients with Atrial Fibrillation
NEJM 361:1139-1151, 1200, Connolly,S.,et al, 2009
Strokes After Cardiac Surgery and Relationship to Carotid Stenosis
Arch Neurol 66:1091-1096, 1062, Li,Y.,et al, 2009
Should I Have an H1N1 Flu Vaccination After Guillain-Barr�
BMJ 339:635, Price,L., 2009
Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009
Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009
Reemergence of PML in Natalizumab-Treated Patients--New Cases, Same Concerns
NEJM 361:1041-1043, Major,E., 2009
Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
Stroke 40:2433-2437,2295, Saver,J.L.,et al, 2009